Aurélia P.
- Country
- France
- Department
- Service de Neurologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 8 partner sites.
Specializations
Wilson Disease Research
This investigator specializes in understanding and treating Wilson disease, a genetic disorder affecting copper metabolism. Their research focuses on developing innovative therapeutic approaches for managing copper levels in patients.
- Copper Metabolism Disorders
- Genetic Disease Management
- Therapeutic Innovation
The investigator evaluates novel treatment modalities including both conventional medications and advanced therapeutic approaches.
Pharmacological Studies
Expertise in conducting research on pharmacokinetic-pharmacodynamic modeling and the evaluation of copper-regulating medications. The investigator studies drug exposure patterns and their effects on various copper biomarkers.
- Drug-exposure Relationships
- Biomarker Analysis
- Patient-specific Response Patterns
Their work involves analyzing complex interactions between medications and copper metabolism markers.
Advanced Therapeutics
The investigator explores cutting-edge therapeutic approaches including gene transfer technologies for treating Wilson disease. Their research encompasses the evaluation of novel biological interventions targeting copper transport mechanisms.
- Gene-based Therapies
- Copper Transport Mechanisms
- Safety Assessment Protocols
Focus includes investigating innovative treatment approaches for improving copper regulation in patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.